Results 141 to 150 of about 2,974 (211)

Real-World Evidence for Oritavancin Use in Gram-Positive Infections

Drugs - Real World Outcomes, 2020
doaj   +1 more source

The UK Antimicrobial Registry (UKAR): an overview of the first 20 months of recruitment. [PDF]

JAC Antimicrob Resist
Sneddon J, Parr R, Woods J, MacDonald RIR, Sandoe JAT, Baltas I, Seaton RA, El Sakka N, Kaye C, Macfarlane GJ, Jones GT, UKAR Study Principal Investigators .   +11 more
europepmc   +1 more source

The future approach for the management of acute bacterial skin and skin structure infections. [PDF]

Curr Opin Infect Dis
Tiseo G, Falcone M.
europepmc   +1 more source

Experience with expanded use of oritavancin in a tertiary hospital: indications, tolerability and outcomes. [PDF]

JAC Antimicrob Resist
Bandaranayake TD, Radcliffe C, Cvercko M, Golden M, Hao RM.   +4 more
europepmc   +1 more source

Management of Recurrent Vancomycin-resistant Enterococcus faecium Bacteremia With Oritavancin: A Case Report. [PDF]

In Vivo
Jalali S, Bhatt H, Thakkar K, Julka R, Pasikhova Y, Verma N.   +5 more
europepmc   +1 more source

In silico molecular targets, docking, dynamics simulation and physiologically based pharmacokinetics modeling of oritavancin. [PDF]

BMC Pharmacol Toxicol
Fatoki TH, Balogun TC, Ojewuyi AE, Omole AC, Olukayode OV, Adewumi AP, Umesi AJ, Ijeoma NP, Apooyin AE, Chinedu CP, Idowu IE, Isah MJ.   +11 more
europepmc   +1 more source

Albumin and Other Plasma Proteins in Pediatric Patients: What, When, and How Much They Influence Antimicrobial Pharmacology. [PDF]

J Pediatr Pharmacol Ther
Angelini J, Russiani F, Ferin S, Flammini S, Tascini C, Roberts JA, Baraldo M, Giuliano S.   +7 more
europepmc   +1 more source

Proportion and antibiogram of methicillin-resistant Staphylococcus aureus (MRSA) in Africa: a systematic review and meta-analysis. [PDF]

Antimicrob Resist Infect Control
Azzam A, Khaled H, Salem A, Sayed M, Mohieldein A, Elsayed MS, Lotfy EM, Abdullah HHAM, Hassan FE, Marei H, Hassan N, Abdulnaby E, Kamel GAM, Osman I, Reda MA, Ismail D, Nazih M, Salem H, Basil A, Rady D.   +19 more
europepmc   +1 more source

Is an oritavancin catheter lock solution active against biofilms of staphylococci and enterococci? [PDF]

Heliyon
Díaz-Navarro M, Cercenado E, Monte A, Visedo A, Rodríguez C, Pérez-Granda MJ, Muñoz P, Guembe M.   +7 more
europepmc   +1 more source